SANGUINE CORPORATION & SUBSIDIARY (A Development Stage Company) Consolidated Statements of Operations (USD $)	12 Months Ended		263 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
REVENUES	$ 0	$ 32,970	$ 224,732
COST OF SALES	0	18,297	18,297
GROSS PROFIT	0	14,673	206,435
OPERATING EXPENSES
Professional fees	183,460	362,309	5,599,242
Research and development	18,102	0	1,991,260
Stock based compensation	986,775	0	986,775
Selling, general and administrative	191,282	58,688	3,070,498
Total Operating Expenses	1,379,619	420,997	11,647,775
LOSS FROM OPERATIONS	(1,379,619)	(406,324)	(11,441,340)
OTHER INCOME (EXPENSE)
Interest income	0	0	40,195
Interest expense	(48,522)	(12,177)	(736,459)
Gain (loss) on foreign currency exchange	0	8,297	(9,099)
Loss on cash deposit	0	0	(10,020)
Gain (loss) on settlement of debt	(1,862)	77,201	1,577,972
Total Other Income (Expense)	(50,384)	73,321	862,589
NET LOSS BEFORE PROVISION FOR INCOME TAX	(1,430,003)	(333,003)	(10,578,751)
PROVISION FOR INCOME TAX	0	0	0
NET LOSS	$ (1,430,003)	$ (333,003)	$ (10,578,751)
BASIC AND DILUTED LOSS PER SHARE	$ (0.21)	$ (0.05)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING -BASIC AND DILUTED	6,881,551	6,682,072